Asia: Market for Medicaments Of Other Antibiotics 2022

Market Size for Medicaments Of Other Antibiotics in Asia

After two years of growth, the Asian medicaments of other antibiotics market decreased by -X% to $X in 2021. The market value increased at an average annual rate of +X% from 2012 to 2021; the trend pattern remained consistent, with somewhat noticeable fluctuations throughout the analyzed period. Over the period under review, the market attained the maximum level at $X in 2020, and then shrank in the following year.

Production of Medicaments Of Other Antibiotics in Asia

In value terms, medicaments of other antibiotics production declined to $X in 2021 estimated in export price. The total output value increased at an average annual rate of +X% over the period from 2012 to 2021; the trend pattern indicated some noticeable fluctuations being recorded throughout the analyzed period. The most prominent rate of growth was recorded in 2017 when the production volume increased by X%. The level of production peaked at $X in 2020, and then shrank in the following year.

Exports of Medicaments Of Other Antibiotics

Exports in Asia

Medicaments of other antibiotics exports soared to X tons in 2021, with an increase of X% against 2020. Total exports indicated resilient growth from 2012 to 2021: its volume increased at an average annual rate of +X% over the last nine-year period. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2021 figures, exports increased by +X% against 2017 indices. As a result, the exports reached the peak and are likely to continue growth in the immediate term.

In value terms, medicaments of other antibiotics exports totaled $X in 2021. The total export value increased at an average annual rate of +X% over the period from 2012 to 2021; however, the trend pattern remained consistent, with somewhat noticeable fluctuations throughout the analyzed period. The most prominent rate of growth was recorded in 2014 when exports increased by X% against the previous year. Over the period under review, the exports reached the maximum in 2021 and are likely to see steady growth in years to come.

Exports by Country

In 2021, China (X tons) represented the main exporter of medicaments of other antibiotics, constituting X% of total exports. It was distantly followed by India (X tons), achieving a X% share of total exports. Japan (X tons), Turkey (X tons) and Jordan (X tons) took a relatively small share of total exports.

China was also the fastest-growing in terms of the medicaments of other antibiotics exports, with a CAGR of +X% from 2012 to 2021. At the same time, Jordan (+X%), India (+X%) and Turkey (+X%) displayed positive paces of growth. By contrast, Japan (-X%) illustrated a downward trend over the same period. While the share of China (+X p.p.) increased significantly in terms of the total exports from 2012-2021, the share of Japan (-X p.p.) and India (-X p.p.) displayed negative dynamics. The shares of the other countries remained relatively stable throughout the analyzed period.

In value terms, the largest medicaments of other antibiotics supplying countries in Asia were India ($X), China ($X) and Japan ($X), with a combined X% share of total exports.

In terms of the main exporting countries, China, with a CAGR of +X%, recorded the highest growth rate of the value of exports, over the period under review, while shipments for the other leaders experienced more modest paces of growth.

Export Prices by Country

The export price in Asia stood at $X per ton in 2021, reducing by -X% against the previous year. Over the period under review, the export price showed a perceptible downturn. The most prominent rate of growth was recorded in 2020 an increase of X%. As a result, the export price reached the peak level of $X per ton, and then contracted sharply in the following year.

Prices varied noticeably by the country of origin: the country with the highest price was Japan ($X per ton), while China ($X per ton) was amongst the lowest.

From 2012 to 2021, the most notable rate of growth in terms of prices was attained by Japan (+X%), while the other leaders experienced mixed trends in the export price figures.

Imports of Medicaments Of Other Antibiotics

Imports in Asia

In 2021, purchases abroad of medicaments of other antibiotics increased by X% to X tons, rising for the second year in a row after two years of decline. The total import volume increased at an average annual rate of +X% over the period from 2012 to 2021; the trend pattern remained relatively stable, with somewhat noticeable fluctuations being observed in certain years. The growth pace was the most rapid in 2017 with an increase of X%. Over the period under review, imports attained the peak figure in 2021 and are likely to see steady growth in the immediate term.

In value terms, medicaments of other antibiotics imports fell to $X in 2021. The total import value increased at an average annual rate of +X% from 2012 to 2021; the trend pattern remained relatively stable, with only minor fluctuations being observed in certain years. The pace of growth appeared the most rapid in 2017 with an increase of X% against the previous year. The level of import peaked at $X in 2018; however, from 2019 to 2021, imports stood at a somewhat lower figure.

Imports by Country

In 2021, Japan (X tons), distantly followed by China (X tons), Vietnam (X tons), Thailand (X tons), Uzbekistan (X tons) and India (X tons) were the main importers of medicaments of other antibiotics, together creating X% of total imports. The following importers - Malaysia (X tons), Iraq (X tons), the Philippines (X tons), Kuwait (X tons), Indonesia (X tons), Yemen (X tons) and Myanmar (X tons) - together made up X% of total imports.

From 2012 to 2021, average annual rates of growth with regard to medicaments of other antibiotics imports into Japan stood at -X%. At the same time, Indonesia (+X%), Uzbekistan (+X%), Kuwait (+X%), India (+X%), Malaysia (+X%), Yemen (+X%), the Philippines (+X%), Vietnam (+X%), Iraq (+X%) and Myanmar (+X%) displayed positive paces of growth. Moreover, Indonesia emerged as the fastest-growing importer imported in Asia, with a CAGR of +X% from 2012-2021. Thailand and China experienced a relatively flat trend pattern. While the share of Uzbekistan (+X p.p.), India (+X p.p.), Indonesia (+X p.p.), Kuwait (+X p.p.), Malaysia (+X p.p.) and Vietnam (+X p.p.) increased significantly in terms of the total imports from 2012-2021, the share of China (-X p.p.) and Japan (-X p.p.) displayed negative dynamics. The shares of the other countries remained relatively stable throughout the analyzed period.

In value terms, China ($X) constitutes the largest market for imported medicaments of other antibiotics in Asia, comprising X% of total imports. The second position in the ranking was held by Japan ($X), with an X% share of total imports. It was followed by Kuwait, with a X% share.

In China, medicaments of other antibiotics imports expanded at an average annual rate of +X% over the period from 2012-2021. The remaining importing countries recorded the following average annual rates of imports growth: Japan (-X% per year) and Kuwait (+X% per year).

Import Prices by Country

The import price in Asia stood at $X per ton in 2021, declining by -X% against the previous year. Overall, the import price showed a relatively flat trend pattern. The pace of growth was the most pronounced in 2018 when the import price increased by X% against the previous year. As a result, import price attained the peak level of $X per ton. From 2019 to 2021, the import prices remained at a lower figure.

There were significant differences in the average prices amongst the major importing countries. In 2021, the country with the highest price was China ($X per ton), while Myanmar ($X per ton) was amongst the lowest.

From 2012 to 2021, the most notable rate of growth in terms of prices was attained by China (+X%), while the other leaders experienced mixed trends in the import price figures.

Source: IndexBox Platform

Frequently Asked Questions (FAQ) :